Neurology Updates

An interim analysis of the phase 3 open-label extension study (RAISE-XT) testing zilucoplan (a self-administered subcutaneous complement C5 inhibitor)…

Eculizumab (Soliris; Alexion) is an intravenous complement C5 inhibitor originally approved by FDA and EMA in adult’s patient with anti-acetylcholine…

Newly elaborated consensus paper based on the Delphi process provides precise diagnostic criteria based on clinical features and paraclinical tests…

In acutely dizzy patients testing for truncal instability is a valuable addition to the HINTS. Grade 2-3 truncal instability has moderate sensitivity…

An interesting neurophysiological and histopathological study that demonstrated structural abnormalities in muscles of patients with musculoskeletal…

Epilepsy has been associated with high mortality, even in patients in monotherapy and those without comorbidities, with causes including…

Adherence to Mediterranean diet has been significantly associated with lower increase in probability of prodromal Parkinson's disease over time in a…

Good diagnostic performance of MDS-MSA criteria against neuropathological diagnosis.

Several viral exposures were recently associated with the risk of neurodegenerative diseases, with the greatest effect association observed between…

Deep intronic GAA-expansions in the FGF14 gene have been recently identified as a common cause of late onset cerebellar ataxia, a disease entity that…

A large study on 147 patients with antibody negative autoimmune encephalitis defines long term outcome and provides important clues on treatment…

Two recent randomized clinical trials showed that thrombectomy is beneficial for patients with stroke with basilar artery occlusion among patients…